Literature DB >> 15128477

Obesity-related hypertension: is there a role for selective leptin resistance?

Marcelo L G Correia1, William G Haynes.   

Abstract

Obesity is a risk factor for cardiovascular diseases, in particular for hypertension. Serum leptin levels and sympathetic nerve activity are both increased in obesity. Leptin has been demonstrated to increase sympathetic nerve activity. Thus, leptin-dependent sympathoactivation might contribute to obesity-related hypertension. However, leptin resistance occurs in obesity. One possibility is that leptin resistance is selective to the metabolic effects of leptin, sparing its sympathoexcitatory actions. In this article, we review experimental evidence supporting the novel concept of selective leptin resistance. We also discuss the sympathetic actions of leptin that are relevant to blood pressure modulation and potential mechanisms of leptin resistance. Disruption of leptin intracellular signaling pathways and resistance of specific leptin-responsive neural networks provide theoretic models of selective leptin resistance. However, most information about leptin-sympathetic actions and leptin-resistance mechanisms derive from in vitro and animal studies. Future research in humans is widely awaited.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128477     DOI: 10.1007/s11906-004-0074-9

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  40 in total

1.  Plasma leptin concentrations and cardiac autonomic nervous system in healthy subjects with different body weights.

Authors:  G Paolisso; D Manzella; N Montano; A Gambardella; M Varricchio
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

2.  Differential modulation of leptin-induced sympathoexcitation by baroreflex activation.

Authors:  Martin Hausberg; Donald A Morgan; Mark A Chapleau; William I Sivitz; Allyn L Mark; William G Haynes
Journal:  J Hypertens       Date:  2002-08       Impact factor: 4.844

3.  Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic.

Authors:  W G Haynes; D A Morgan; A Djalali; W I Sivitz; A L Mark
Journal:  Hypertension       Date:  1999-01       Impact factor: 10.190

4.  Impaired transport of leptin across the blood-brain barrier in obesity.

Authors:  W A Banks; C R DiPalma; C L Farrell
Journal:  Peptides       Date:  1999-11       Impact factor: 3.750

5.  Physiological response to long-term peripheral and central leptin infusion in lean and obese mice.

Authors:  J L Halaas; C Boozer; J Blair-West; N Fidahusein; D A Denton; J M Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

6.  Pathophysiological role of leptin in obesity-related hypertension.

Authors:  M Aizawa-Abe; Y Ogawa; H Masuzaki; K Ebihara; N Satoh; H Iwai; N Matsuoka; T Hayashi; K Hosoda; G Inoue; Y Yoshimasa; K Nakao
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

7.  Elevated serum leptin concentrations in women with components of multiple risk factor clustering syndrome.

Authors:  M Matsubara; H Chiba; S Maruoka; S Katayose
Journal:  J Atheroscler Thromb       Date:  2000       Impact factor: 4.928

8.  Chronic leptin infusion increases arterial pressure.

Authors:  E W Shek; M W Brands; J E Hall
Journal:  Hypertension       Date:  1998-01       Impact factor: 10.190

9.  Enhanced de novo lipogenesis in the leptin-unresponsive pancreatic islets of prediabetic Zucker diabetic fatty rats: role in the pathogenesis of lipotoxic diabetes.

Authors:  Y T Zhou; M Shimabukuro; Y Lee; K Koyama; M Higa; T Ferguson; R H Unger
Journal:  Diabetes       Date:  1998-12       Impact factor: 9.461

10.  Weight-reducing effects of the plasma protein encoded by the obese gene.

Authors:  J L Halaas; K S Gajiwala; M Maffei; S L Cohen; B T Chait; D Rabinowitz; R L Lallone; S K Burley; J M Friedman
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

View more
  8 in total

1.  Adipokine profile and urinary albumin excretion in isolated growth hormone deficiency.

Authors:  Carla R P Oliveira; Roberto Salvatori; Rafael A Meneguz-Moreno; Manuel H Aguiar-Oliveira; Rossana M C Pereira; Eugênia H A Valença; Vanessa P Araujo; Natália T Farias; Débora C R Silveira; Jose G H Vieira; Jose A S Barreto-Filho
Journal:  J Clin Endocrinol Metab       Date:  2009-12-16       Impact factor: 5.958

Review 2.  Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease.

Authors:  Seth S Martin; Atif Qasim; Muredach P Reilly
Journal:  J Am Coll Cardiol       Date:  2008-10-07       Impact factor: 24.094

3.  Vascular smooth muscle-specific deletion of the leptin receptor attenuates leptin-induced alterations in vascular relaxation.

Authors:  Michael J Ryan; T Taylor Coleman; Jennifer M Sasser; Katarina M Pittman; Michael W Hankins; David E Stec
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-03-02       Impact factor: 3.619

Review 4.  Cardiac remodeling in obesity.

Authors:  E Dale Abel; Sheldon E Litwin; Gary Sweeney
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

5.  Obesity, periodontal and general health: Relationship and management.

Authors:  Parveen Dahiya; Reet Kamal; Rajan Gupta
Journal:  Indian J Endocrinol Metab       Date:  2012-01

6.  Leptin and uric acid as predictors of metabolic syndrome in jordanian adults.

Authors:  Ahmad A Obeidat; Mousa N Ahmad; Fares H Haddad; Firas S Azzeh
Journal:  Nutr Res Pract       Date:  2016-04-26       Impact factor: 1.926

Review 7.  Adipocyte-Based Cell Therapy in Oncology: The Role of Cancer-Associated Adipocytes and Their Reinterpretation as Delivery Platforms.

Authors:  Raluca Munteanu; Anca Onaciu; Cristian Moldovan; Alina-Andreea Zimta; Diana Gulei; Angelo V Paradiso; Vladimir Lazar; Ioana Berindan-Neagoe
Journal:  Pharmaceutics       Date:  2020-04-28       Impact factor: 6.321

Review 8.  The underlying mechanisms for development of hypertension in the metabolic syndrome.

Authors:  Hidekatsu Yanai; Yoshiharu Tomono; Kumie Ito; Nobuyuki Furutani; Hiroshi Yoshida; Norio Tada
Journal:  Nutr J       Date:  2008-04-17       Impact factor: 3.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.